Replicel
Collapse
X
-
Actually it is Q3 2013 -
Phase II begins in January 2012 - they wont wait out the full 27 months of Phase I before beginning Phase II - they have stated that Phase II trials shall start in January next year in Canada, during that period follow-ups for Phase I shall continue on into 2013.Comment
-
Actually it is Q3 2013 -
Phase II begins in January 2012 - they wont wait out the full 27 months of Phase I before beginning Phase II - they have stated that Phase II trials shall start in January next year in Canada, during that period follow-ups for Phase I shall continue on into 2013.
Originally posted by FlowersThey said final data analysis is Q3 2011. So thats a little over 2 years from now. We'll see.... .Comment
-
flowers, you dont foresee them having any setbacks at all? They havent even entered phase 1 and you guys think they will have all data by end of 2013? I serious dont see that happening.
I want this as much as the next guy but we keep biting on all these very optimistic time lines and then get disappointed and angry a year later when they are way behind.
earliest I see follica histogen or this hitting market is 2016 but everyone is entitled to their opinionComment
-
Depends on how earlythey did actually start their stuff, they are not forced to tell us exactly when they started, and right now i wont blieve any of those companies with their timelines.
Gut feeling tells me they are aiming for a faster market entrance to grab more money, even thy know there is competition right now. I mean ARI was very slow and calm when it came to news but when Histogen entered the spot and also others, they woke up from their lethargic thing and started to go full frontal.
Its good to have different solutions but i think in the end the patient will be irritated because he wont know which thing suits him best, its to much and to many.Comment
-
6 months in
CAlex why are you just ignoring the facts? I know we don't know for sure that they'll def keep to the timeline but you've said twice that they haven't even started trials yet which is completely false! They started trials in Dec 10 which means they're about 6 months in.Comment
-
By the looks of things, I seriously doubt these guys will beat Aderans to market by 2014 if everything for them goes to plan, we havn't heard anything from Aderans in a while, only that they've been discussing their findings across the globe, which is classic "we need investment" behaviour. That said I would never rule out Aderans, they have shown 70%+ increase during Phase II already of their most powerful compound, that is exciting news to share with the world for sure.
Histogen begin recruitment for Phase I/II in a few weeks, granted they have been held back by the devastating tsunami in Japan, but we will know if they have an effective safe procedure by the end of this year, I highly doubt there will be any further safety issues if they can get through this upcoming trial without any hindrance.
Stay positive - in no time like the present have we had the fortune to experience so many potential treatments in the pipeline, and who knows even, an unknown company working away in the shadows out there may crop up with the answer before all of the companies we currently have our eyes on.Comment
-
I find it weird how all these companies claim that they're going to release their product roughly at the end 2013/early 2014 just when propecia patent runs out. Very strange indeed.Comment
-
UK is right. We have a reason to be grateful knowing different companies are working on something.
The Big 4
ARI
Replicel
Follica
Histogen
Somehow I feel Follica will surprise everyone and come out before anyone since they keep their shit low pro. They always seem to be discovering new shit.Comment
Comment